Amgen secures five-year ban on psoriasis drug copycat

20-04-2023

Liz Hockley

Amgen secures five-year ban on psoriasis drug copycat

Pavel Kapysh / Shutterstock.com

Court affirms decision that two Otezla patents are not invalid | Apremilast generics set for 2028 release.


Amgen, Sandoz, Zydus, Otezla, apremilast, patents, psoriasis

LSIPR